Sbi Securities Co., Ltd. Exagen Inc. Transaction History
Sbi Securities Co., Ltd.
- $3.25 Trillion
- Q4 2024
A detailed history of Sbi Securities Co., Ltd. transactions in Exagen Inc. stock. As of the latest transaction made, Sbi Securities Co., Ltd. holds 5,050 shares of XGN stock, worth $26,007. This represents 0.0% of its overall portfolio holdings.
Number of Shares
5,050Holding current value
$26,007% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding XGN
# of Institutions
36Shares Held
6.37MCall Options Held
4.5KPut Options Held
400-
Rtw Investments, LP New York, NY1.51MShares$7.79 Million0.07% of portfolio
-
Cowen And Company, LLC891KShares$4.59 Million0.07% of portfolio
-
Silvercrest Asset Management Group LLC New York, NY541KShares$2.79 Million0.01% of portfolio
-
Stonepine Capital Management, LLC Bend, OR534KShares$2.75 Million1.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA491KShares$2.53 Million0.0% of portfolio
About EXAGEN INC.
- Ticker XGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 16,260,400
- Market Cap $83.7M
- Description
- Exagen Inc. develops and commercializes various testing products based on its cell-bound complement activation products technology under the AVISE brand in the United States. It enables rheumatologists to care for patients through the diagnosis, prognosis, and monitoring of autoimmune and autoimmune-related diseases, including systemic lupus ery...